In a recent Orthopedic Design & Technology Q&A, Onkos Surgical Founder & CEO Patrick Treacy shares how patient-specific design, 3D printing, and antibacterial innovation are shaping the future of complex orthopaedic care—including strategies to help address bacterial contamination in high-risk procedures with NanoCept®, the first FDA-granted antibacterial technology for orthopaedic implants.
Read the full interview to learn how Onkos continues to advance limb salvage with NanoCept® on the ELEOS™ Limb Salvage System and patient specific 3D printed implants with My3D® Personalized Solutions.
Click here for the full interview: Built to Heal, Designed to Defend: A Q&A with Onkos Surgical’s CEO